BioMarin Pharmaceutical Inc.
announced an offering, subject to
market and other conditions, of
1.5m shares of its common stock in
an underwritten public offering.
According to Globe Newswire,
the company plans to use the
proceeds primarily for the purchase
of its corporate headquarters for
$116.5m and for general purposes.
The number of shares on offer
is approximately 1% of shares of
common stock outstanding as of 31
Dec 2013.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Mar 14
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.